Herpes virus reactivation in brain-injured patients : The IBIS virus study

Size: px
Start display at page:

Download "Herpes virus reactivation in brain-injured patients : The IBIS virus study"

Transcription

1 Herpes virus reactivation in brain-injured patients : role and mechanisms of CD4 T cell defects. The IBIS virus study Antoine Roquilly University Hospital of Nantes, France UPRES 386 Medical University of Nantes, France

2 Déclaration d intérêts de 14 à 17 Intérêts financiers : néant Liens durables ou permanents : néant Interventions ponctuelles : néant Intérêts indirects : MSD

3 Critical-illness related immunosuppression / Virome Hotchkiss et al. Nature Immunol 13 De Vlaminck et al. Cell 13

4 The IBIS Virus project Herpes simplex Virus 49 patients 19 Traumatic brain injuries 1 SubArachnoid Hemorrhage 39 Stroke 77 (3%) serology negative 17 (71%) serology positive (3%) in-icu acquisition blood lungs 14 (6%) without reactivation NA blood NA lungs 68 (4%) with reactivation 13 blood 66 lungs 11 (14%) in-icu death 1 (16%) death (6 months) 18 (17%) in-icu death (19%) death (6 months) 17 (%) in-icu death (9%) death (6 months)

5 Risk of HSV and CMV reactivations in 49 brain-injured patients

6 Association of HSV reactivation with poor in-icu outcomes

7 Association of CMV reactivation with outcomes

8 HSV reactivations are associated with poor neurological outcome

9 Working hypothesis : BI-induced immunosuppression is responsible for Herpes Simplex Virus reactivation WP 1 : Increased viral replication or loss of immune control?

10 TT viral load (log/ml) Decreased circulating viral load of Torque Teno Virus in BI patients without HSV reactivation 3 1 volunteer HSV reactivation no HSV reactivation controls day 1 day 4 day 7 6 months

11 Working hypothesis : BI-induced T cell defects are responsible for Herpes Simplex Virus reactivation WP : Does the number of T cells matter?

12 Spleen volume (cm 3 ) CD4 T cells CD4 T cells Lymphopenia after brain injury IBIS - biocollection Essai clinique randomisé ** Modeles murins Sham day 1 day 7 TBI 4 *** * Sham Day 1 Day 8 Sham day 1 TBI day 7

13 No proof of apoptosis / necrosis of lymphocytes in Spleen Tissue after brain-injury cleaved-caspase-3 + cells per field (counts) Mode IBIS - biocollection Sham Brain injury human Activated Caspase control sham trauma Brain-dead patient white pulp red pulp Classical histology Activated Caspase 3

14 Lymphopenia is not associated with HSV reactivation, just a marker of severity? Lymphocytes (cells/mm 3 ) Lymphocytes (cells/mm 3 ) 1 1 p= No Yes HSV reactivation Survivors Non survivors

15 Working hypothesis : BI-induced T cell defects are responsible for the severity of HSV reactivation WP 3 : Do functions of T cells matter?

16 % of IFNg + EM Tcell % of IFNg + CM Tcell IFN-γ + CD8 T cells (%) IFN-γ + CD4 T cells (%) % of IFNg + Effe Tcell Defective production of IFN-g by memory CD4 T cells HD Day 1 Day 7 Month HD ** * J1 J7 M6 1 1 HD Day1 Day 7 Month 6 1 HD Day1 Day 7 Month * HD Day1 Day 7 Month 6

17 PD1 MFI Altered T cells are not exhausted CD4 CFSE en % Patient CD4 CFSE en % Patient Number of T cell division CD8 CFSE en % CD8 CFSE en % * * 1 * * Number of T cell division Patient Patient -4-6 IBIS d1 IBIS d4-7 CTL IBIS d1 IBIS d4-7 CTL IBIS d1 IBIS d4-7 CTL CD4 CD8 CD3

18 % of FoxP3+ CD4 % of RORgT+ CD4 % of T-bet + CD4 T cells % of GATA-3+ CD4 Brain injury alters the transcriptional factor program of CD4 T ** 1 ** * Day 1 Day 7 Month 6 Day 1 Day 7 Month Day 1 Day 7 Month 6 Day 1 Day 7 Month 6

19 TT viral load (log/ml) % IL-4 T CD4+ % IL- T CD4+ CD4 T cells re-programming is associated with immunosuppression and HSV reactivation R =.1, p=.8 Immune competence ** ** 4 6 %IL4 T cells IL4 re-programming No reactivation HSV reactivation Re-programming No reactivation HSV reactivation

20 Working hypothesis : BI-induced T cell defects are responsible for the severity of HSV reactivation WP 4 : Several mechanisms the CD4 T cells reprogramming?

21 CD4 T cells reprogramming and soluble circulating mediators? IBIS - biocollection Essai clinique randomisé IBIS - biocollection Essai clinique randomisé serum PBMCs Modeles murins serum Modeles murins

22 CD4 T cells reprogramming is continuously maintained by CD14+ cells, and other mediators are involved % of IFNg + CD4 Tcell % of IFNg + CD4 Tcell % of IL4+ CD4 % of IL4+ CD4 Tcell IFN-γ+ (% of CD4 T cells) IFN-γ+ (% of CD4 T cells) IBIS - biocollection Essai clinique randomisé PBMCs ** PBMCs Modeles murins CD4 T cells + CD14 cells 1 1 NT CD4 + PBMC ** CD4 CD NT CD4 + PBMC *** CD4 CD4 1 PBMC CD4 CD4+CD14 PBMC - CD PBMC CD4 CD4+cDC PBMC - cdc

23 %IFN-γ+ CD4 T cells IL4+ CD4 T cells (%) CD4 T cells reprogramming is partially IL-4 dependent, but not TGF-b dependent IBIS - biocollection Essai clinique randomisé Blocking antibody Y Y Modeles murins 3 1 ** Brain injury PBMCs Vehicle Anti IL-4 Vehicle anti-il4 isotypique Ctrl Anti TGFb Brain injury Vehicle anti-il4 isotypique Ctrl Anti TGFb

24 Conclusions HSV reactivations are common in brain injured patients, associated with poor outcome Long-lasting lymphopenia No apoptosis (caspase ko mice?) Not associated with HSV reactivation Long lasting TF reprogramming of CD4 T cells after BI No exhaustion Altered TF reprogramming of CD4 T cells is associated with HSV reactivation Microenvironment : CD14, IL-4. Other mechanisms under the scope : epigenetic modifications? CD14 cells? Role of direct activation by brain-released DAMPs?

25 Acknowledgments C. Bressollette (UMR 164) M. Burelle A. Irimia C. Bossard (URM 187) T. Woodberry (Darwin Uni) Pr Asehnoune lab Tanguy Roman (PhD) Barbara Misme-Aucouturier (PhD) Cédric Jacqueline (PhD) Alexis Broquet (PhD) Intensive Care Unit - CHU Nantes Raphael Cinotti (MD) Mickael Vourc h (MD) Delphine Flattres (TEC)

New evidences. Biomarkers to explore immunoparalysis: what future for immunostimulation? B. François CHU Limoges (France)

New evidences. Biomarkers to explore immunoparalysis: what future for immunostimulation? B. François CHU Limoges (France) New evidences Biomarkers to explore immunoparalysis: what future for immunostimulation? B. François CHU Limoges (France) Background Hotchkiss, NEJM 2003 New understanding of response in sepsis PICS Persistent

More information

Supplementary Figure 1. IL-12 serum levels and frequency of subsets in FL patients. (A) IL-12

Supplementary Figure 1. IL-12 serum levels and frequency of subsets in FL patients. (A) IL-12 1 Supplementary Data Figure legends Supplementary Figure 1. IL-12 serum levels and frequency of subsets in FL patients. (A) IL-12 serum levels measured by multiplex ELISA (Luminex) in FL patients before

More information

Supplementary Figure 1. Double-staining immunofluorescence analysis of invasive colon and breast cancers. Specimens from invasive ductal breast

Supplementary Figure 1. Double-staining immunofluorescence analysis of invasive colon and breast cancers. Specimens from invasive ductal breast Supplementary Figure 1. Double-staining immunofluorescence analysis of invasive colon and breast cancers. Specimens from invasive ductal breast carcinoma (a) and colon adenocarcinoma (b) were staining

More information

Measles virus vaccine induces oncolysis of tumor cells and activates immune responses.

Measles virus vaccine induces oncolysis of tumor cells and activates immune responses. Measles virus vaccine induces oncolysis of tumor cells and activates immune responses. Marc Grégoire*, J.-F. Fonteneau, N. Boisgerault, J.-B. Guillerme and F. Tangy. * INSERM, Nantes, F-44, France. Pasteur

More information

Parallels between cancer and infectious disease

Parallels between cancer and infectious disease Washington University School of Medicine Digital Commons@Becker Open Access Publications 2014 Parallels between cancer and infectious disease Richard S. Hotchkiss Washington University School of Medicine

More information

Examples of questions for Cellular Immunology/Cellular Biology and Immunology

Examples of questions for Cellular Immunology/Cellular Biology and Immunology Examples of questions for Cellular Immunology/Cellular Biology and Immunology Each student gets a set of 6 questions, so that each set contains different types of questions and that the set of questions

More information

Herpesviruses. Tools of diagnosis : what to use and when. Corinne Liesnard Laboratory of Virology Erasme Hospital - ULB

Herpesviruses. Tools of diagnosis : what to use and when. Corinne Liesnard Laboratory of Virology Erasme Hospital - ULB Herpesviruses Tools of diagnosis : what to use and when Corinne Liesnard Laboratory of Virology Erasme Hospital - ULB Evolution of the techniques in the virology lab Techniques : "Classic" methods Ag detection

More information

2/16/2018. The Immune System and Cancer. Fatal Melanoma Transferred in a Donated Kidney 16 years after Melanoma Surgery

2/16/2018. The Immune System and Cancer. Fatal Melanoma Transferred in a Donated Kidney 16 years after Melanoma Surgery C007: Immunology of Melanoma: Mechanisms of Immune Therapies Delphine J. Lee, MD, PhD Chief and Program Director, Dermatology, Harbor UCLA Medical Center Principal Investigator, Los Angeles Biomedical

More information

Immunoadjuvant Properties of Oncolytic Schwarz Measles Virus

Immunoadjuvant Properties of Oncolytic Schwarz Measles Virus Immunoadjuvant Properties of Oncolytic Schwarz Measles Virus Dr Jean-François Fonteneau Institut de Recherche en Santé de l Université de Nantes INSERM UMR892, CNRS UMR6299 Nantes, France Anti-tumor Virotherapy

More information

Novel RORg Agonists Enhance Anti-Tumor Activity of Adoptive T Cell Therapy

Novel RORg Agonists Enhance Anti-Tumor Activity of Adoptive T Cell Therapy Novel RORg Agonists Enhance Anti-Tumor Activity of Adoptive T Cell Therapy Jacques Moisan, Kinga Majchrzak, Xiao Hu, Rodney Morgan, Xikui Liu, Kellie Demock, Yahong Wang, Charles Lesch, Brian Sanchez,

More information

Cellular Immunity in Aging and HIV: Correlates of Protection. Immune Senescence

Cellular Immunity in Aging and HIV: Correlates of Protection. Immune Senescence Cellular Immunity in Aging and HIV: Correlates of Protection Janet E. McElhaney, MD Professor of Medicine Allan M. McGavin Chair in Research Geriatrics University of British Columbia Vancouver, BC and

More information

Supplemental Figure 1

Supplemental Figure 1 Supplemental Figure 1 1a 1c PD-1 MFI fold change 6 5 4 3 2 1 IL-1α IL-2 IL-4 IL-6 IL-1 IL-12 IL-13 IL-15 IL-17 IL-18 IL-21 IL-23 IFN-α Mut Human PD-1 promoter SBE-D 5 -GTCTG- -1.2kb SBE-P -CAGAC- -1.kb

More information

La risposta immune all infezione da virus ebola. Chiara Agrati, PhD

La risposta immune all infezione da virus ebola. Chiara Agrati, PhD La risposta immune all infezione da virus ebola Chiara Agrati, PhD Pathogenetic mechanisms This virus infection is able to: - disable the immune system, preventing an effective protective immune response

More information

Supplemental Materials for. Effects of sphingosine-1-phosphate receptor 1 phosphorylation in response to. FTY720 during neuroinflammation

Supplemental Materials for. Effects of sphingosine-1-phosphate receptor 1 phosphorylation in response to. FTY720 during neuroinflammation Supplemental Materials for Effects of sphingosine-1-phosphate receptor 1 phosphorylation in response to FTY7 during neuroinflammation This file includes: Supplemental Table 1. EAE clinical parameters of

More information

Micro 204. Cytotoxic T Lymphocytes (CTL) Lewis Lanier

Micro 204. Cytotoxic T Lymphocytes (CTL) Lewis Lanier Micro 204 Cytotoxic T Lymphocytes (CTL) Lewis Lanier Lewis.Lanier@ucsf.edu Lymphocyte-mediated Cytotoxicity CD8 + αβ-tcr + T cells CD4 + αβ-tcr + T cells γδ-tcr + T cells Natural Killer cells CD8 + αβ-tcr

More information

Supplementary Figure 1. ETBF activate Stat3 in B6 and Min mice colons

Supplementary Figure 1. ETBF activate Stat3 in B6 and Min mice colons Supplementary Figure 1 ETBF activate Stat3 in B6 and Min mice colons a pstat3 controls Pos Neg ETBF 1 2 3 4 b pstat1 pstat2 pstat3 pstat4 pstat5 pstat6 Actin Figure Legend: (a) ETBF induce predominantly

More information

Supplementary Table 1 Clinicopathological characteristics of 35 patients with CRCs

Supplementary Table 1 Clinicopathological characteristics of 35 patients with CRCs Supplementary Table Clinicopathological characteristics of 35 patients with CRCs Characteristics Type-A CRC Type-B CRC P value Sex Male / Female 9 / / 8.5 Age (years) Median (range) 6. (9 86) 6.5 (9 76).95

More information

Institute t of Experimental Immunology University of Bonn, Germany

Institute t of Experimental Immunology University of Bonn, Germany How T cells recognize antigen Christian Kurts Institute t of Experimental Immunology University of Bonn, Germany When do T cells recognize antigen? Antigen uptake Activation phase 1st recognition Effector

More information

New insights into CD8+ T cell function and regulation. Pam Ohashi Princess Margaret Cancer Centre

New insights into CD8+ T cell function and regulation. Pam Ohashi Princess Margaret Cancer Centre New insights into CD8+ T cell function and regulation Pam Ohashi Princess Margaret Cancer Centre New insights into CD8+ T cell function and regulation Pam Ohashi Princess Margaret Cancer Centre No Disclosures

More information

The role of CMV in the long term outcome for older Australians, renal transplant recipients and HIV patients

The role of CMV in the long term outcome for older Australians, renal transplant recipients and HIV patients The role of in the long term outcome for older Australians, renal transplant recipients and HIV Some well known facts is a herpes virus so it is has a DNA genome It replicates in fibroblasts, monocytes

More information

Immune Checkpoints. PD Dr med. Alessandra Curioni-Fontecedro Department of Hematology and Oncology Cancer Center Zurich University Hospital Zurich

Immune Checkpoints. PD Dr med. Alessandra Curioni-Fontecedro Department of Hematology and Oncology Cancer Center Zurich University Hospital Zurich Immune Checkpoints PD Dr med. Alessandra Curioni-Fontecedro Department of Hematology and Oncology Cancer Center Zurich University Hospital Zurich Activation of T cells requires co-stimulation Science 3

More information

Innate immunity. Abul K. Abbas University of California San Francisco. FOCiS

Innate immunity. Abul K. Abbas University of California San Francisco. FOCiS 1 Innate immunity Abul K. Abbas University of California San Francisco FOCiS 2 Lecture outline Components of innate immunity Recognition of microbes and dead cells Toll Like Receptors NOD Like Receptors/Inflammasome

More information

The central role of T helper cells

The central role of T helper cells e central role of T helper s the expanding universe of lineages Cytometric analysis of T function Hyun-Dong Chang Deutsches Rheuma-Forschungszentrum Berlin, a Leibniz Institute, Berlin, Germany CD8+ T

More information

Loss of CD96 Expression as a New Biomarker for T-cell Senescence in HIV-1 Infection

Loss of CD96 Expression as a New Biomarker for T-cell Senescence in HIV-1 Infection Loss of CD96 Expression as a New Biomarker for T-cell Senescence in HIV-1 Infection Mohamed El-Far, PhD CHUM research center (CRCHUM) University of Montreal, QC Canada 6th International Workshop on HIV

More information

Objectives. Abbas Chapter 11: Immunological Tolerance. Question 1. Question 2. Question 3. Definitions

Objectives. Abbas Chapter 11: Immunological Tolerance. Question 1. Question 2. Question 3. Definitions Objectives Abbas Chapter 11: Immunological Tolerance Christina Ciaccio, MD Children s Mercy Hospitals and Clinics February 1, 2010 To introduce the concept of immunologic tolerance To understand what factors

More information

Supplemental Materials

Supplemental Materials Supplemental Materials Programmed death one homolog maintains the pool size of regulatory T cells by promoting their differentiation and stability Qi Wang 1, Jianwei He 1, Dallas B. Flies 2, Liqun Luo

More information

Cytotoxicity assays. Rory D. de Vries, PhD 1. Viroscience lab, Erasmus MC, Rotterdam, the Netherlands

Cytotoxicity assays. Rory D. de Vries, PhD 1. Viroscience lab, Erasmus MC, Rotterdam, the Netherlands Cytotoxicity assays Rory D. de Vries, PhD 1 1 Viroscience lab, Erasmus MC, Rotterdam, the Netherlands Anti-influenza immunity Humoral / CD4+ / CD8+ / NK? Function of CTL Elimination of virus-infected cells?

More information

Feb 11, Gene Therapy. Sam K.P. Kung Immunology Rm 417 Apotex Center

Feb 11, Gene Therapy. Sam K.P. Kung Immunology Rm 417 Apotex Center Gene Therapy Sam K.P. Kung Immunology Rm 417 Apotex Center Objectives: The concept of gene therapy, and an introduction of some of the currently used gene therapy vector Undesirable immune responses to

More information

Effect of Cytomegalovirus Infection on Immune Responsiveness. Rene van Lier Sanquin Blood Supply Foundation

Effect of Cytomegalovirus Infection on Immune Responsiveness. Rene van Lier Sanquin Blood Supply Foundation Effect of Cytomegalovirus Infection on Immune Responsiveness Rene van Lier Sanquin Blood Supply Foundation OUTLINE CMV infection and vaccination responses Effects of CMV infection on CD8 + T cell numbers

More information

CD4+ T Helper T Cells, and their Cytokines in Immune Defense and Disease

CD4+ T Helper T Cells, and their Cytokines in Immune Defense and Disease CD4+ T Helper T Cells, and their Cytokines in Immune Defense and Disease Andrew Lichtman M.D., Ph.D. Brigham and Women s Hospital Harvard Medical School Lecture outline Intro to T cell mediated immunity

More information

Supplemental Table I.

Supplemental Table I. Supplemental Table I Male / Mean ± SEM n Mean ± SEM n Body weight, g 29.2±0.4 17 29.7±0.5 17 Total cholesterol, mg/dl 534.0±30.8 17 561.6±26.1 17 HDL-cholesterol, mg/dl 9.6±0.8 17 10.1±0.7 17 Triglycerides,

More information

Supplementary Figure 1. mrna expression of chitinase and chitinase-like protein in splenic immune cells. Each splenic immune cell population was

Supplementary Figure 1. mrna expression of chitinase and chitinase-like protein in splenic immune cells. Each splenic immune cell population was Supplementary Figure 1. mrna expression of chitinase and chitinase-like protein in splenic immune cells. Each splenic immune cell population was sorted by FACS. Surface markers for sorting were CD11c +

More information

Oncolytic Immunotherapy: A Local and Systemic Antitumor Approach

Oncolytic Immunotherapy: A Local and Systemic Antitumor Approach Oncolytic Immunotherapy: A Local and Systemic Antitumor Approach Oncolytic immunotherapy Oncolytic immunotherapy the use of a genetically modified virus to attack tumors and induce a systemic immune response

More information

Figure S1 Generation of γ-gt DTR transgenic mice. (A) Schematic construct of the transgene. (B)

Figure S1 Generation of γ-gt DTR transgenic mice. (A) Schematic construct of the transgene. (B) Figure S1 Generation of γ-gt DTR transgenic mice. (A) Schematic construct of the transgene. (B) PCR identified expected hhb-egf band (left panel) and HA tag band (right) in kidneys of transgenic (TG) mice

More information

Chronic Viral Infections vs. Our Immune System: Revisiting our view of viruses as pathogens

Chronic Viral Infections vs. Our Immune System: Revisiting our view of viruses as pathogens Chronic Viral Infections vs. Our Immune System: Revisiting our view of viruses as pathogens Tiffany A. Reese Assistant Professor Departments of Immunology and Microbiology Challenge your idea of classic

More information

-738 proteins were found only in the ME subjects proteins were only found in PTLS samples proteins were only found in the normal controls.

-738 proteins were found only in the ME subjects proteins were only found in PTLS samples proteins were only found in the normal controls. RECENT RESEARCH Currently there is much exciting research being published including the Schutzer et al. study that compared cerebrospinal fluid proteomes to differentiate ME and Post Treatment Lyme Syndrome

More information

Shiv Pillai Ragon Institute, Massachusetts General Hospital Harvard Medical School

Shiv Pillai Ragon Institute, Massachusetts General Hospital Harvard Medical School CTLs, Natural Killers and NKTs 1 Shiv Pillai Ragon Institute, Massachusetts General Hospital Harvard Medical School CTL inducing tumor apoptosis 3 Lecture outline CD8 + Cytotoxic T lymphocytes (CTL) Activation/differentiation

More information

CD25-PE (BD Biosciences) and labeled with anti-pe-microbeads (Miltenyi Biotec) for depletion of CD25 +

CD25-PE (BD Biosciences) and labeled with anti-pe-microbeads (Miltenyi Biotec) for depletion of CD25 + Supplements Supplemental Materials and Methods Depletion of CD25 + T-cells from PBMC. Fresh or HD precultured PBMC were stained with the conjugate CD25-PE (BD Biosciences) and labeled with anti-pe-microbeads

More information

Clinical Aspect and Application of Laboratory Test in Herpes Virus Infection. Masoud Mardani M.D,FIDSA

Clinical Aspect and Application of Laboratory Test in Herpes Virus Infection. Masoud Mardani M.D,FIDSA Clinical Aspect and Application of Laboratory Test in Herpes Virus Infection Masoud Mardani M.D,FIDSA Shahidhid Bh BeheshtiMdi Medical lui Universityit Cytomegalovirus (CMV), Epstein Barr Virus(EBV), Herpes

More information

Viruses. Poxviridae. DNA viruses: 6 families. Herpesviridae Adenoviridae. Hepadnaviridae Papovaviridae Parvoviridae

Viruses. Poxviridae. DNA viruses: 6 families. Herpesviridae Adenoviridae. Hepadnaviridae Papovaviridae Parvoviridae Viruses DNA viruses: 6 families Poxviridae Herpesviridae Adenoviridae Hepadnaviridae Papovaviridae Parvoviridae Human herpesviruses Three subfamilies (genome structure, tissue tropism, cytopathologic effect,

More information

VISTA, a novel immune checkpoint protein ligand that suppresses anti-tumor tumor T cell responses. Li Wang. Dartmouth Medical School

VISTA, a novel immune checkpoint protein ligand that suppresses anti-tumor tumor T cell responses. Li Wang. Dartmouth Medical School VISTA, a novel immune checkpoint protein ligand that suppresses anti-tumor tumor T cell responses Li Wang Dartmouth Medical School The B7 Immunoglobulin Super-Family immune regulators APC T cell Co-stimulatory:

More information

Supplementary. presence of the. (c) mrna expression. Error. in naive or

Supplementary. presence of the. (c) mrna expression. Error. in naive or Figure 1. (a) Naive CD4 + T cells were activated in the presence of the indicated cytokines for 3 days. Enpp2 mrna expression was measured by qrt-pcrhr, infected with (b, c) Naive CD4 + T cells were activated

More information

Supplementary Figure 1. Efficiency of Mll4 deletion and its effect on T cell populations in the periphery. Nature Immunology: doi: /ni.

Supplementary Figure 1. Efficiency of Mll4 deletion and its effect on T cell populations in the periphery. Nature Immunology: doi: /ni. Supplementary Figure 1 Efficiency of Mll4 deletion and its effect on T cell populations in the periphery. Expression of Mll4 floxed alleles (16-19) in naive CD4 + T cells isolated from lymph nodes and

More information

Supplementary Figure 1.

Supplementary Figure 1. Supplementary Figure 1. Female Pro-ins2 -/- mice at 5-6 weeks of age were either inoculated i.p. with a single dose of CVB4 (1x10 5 PFU/mouse) or PBS and treated with αgalcer or control vehicle. On day

More information

WIN 2015 Symposium Radiation and immunology: a new therapeutic partnership

WIN 2015 Symposium Radiation and immunology: a new therapeutic partnership WIN 215 Symposium Radiation and immunology: a new therapeutic partnership Dr. Ralph Weichselbaum Conflict of Interest Nothing to Disclose Limitations of Radiotherapy Radiotherapy cannot be given in high

More information

MYOCARDITIS AND BIOMARKERS. Dr C. Guenancia Service de Cardiologie CHU Dijon

MYOCARDITIS AND BIOMARKERS. Dr C. Guenancia Service de Cardiologie CHU Dijon MYOCARDITIS AND BIOMARKERS Dr C. Guenancia Service de Cardiologie CHU Dijon Déclaration de Relations Professionnelles Disclosure Statement of Financial Interest J'ʹai actuellement, ou j'ʹai eu au cours

More information

Lab 2: Diagnostic Tests in Clinical Virology Laboratories 450 MIC PRACTICAL PART SECTION (30397) 2018 (450 MIC) AMAL ALGHAMDI - HUDA ALKHTEEB 1

Lab 2: Diagnostic Tests in Clinical Virology Laboratories 450 MIC PRACTICAL PART SECTION (30397) 2018 (450 MIC) AMAL ALGHAMDI - HUDA ALKHTEEB 1 Lab 2: Diagnostic Tests in Clinical Virology Laboratories 450 MIC PRACTICAL PART SECTION (30397) 2018 (450 MIC) AMAL ALGHAMDI - HUDA ALKHTEEB 1 Diagnostic Virology Virus Isolation and Cultivation Viral

More information

Supplementary Figures

Supplementary Figures Supplementary Figures Supplementary Figure 1. NKT ligand-loaded tumour antigen-presenting B cell- and monocyte-based vaccine induces NKT, NK and CD8 T cell responses. (A) The cytokine profiles of liver

More information

Herpesviruses. Virion. Genome. Genes and proteins. Viruses and hosts. Diseases. Distinctive characteristics

Herpesviruses. Virion. Genome. Genes and proteins. Viruses and hosts. Diseases. Distinctive characteristics Herpesviruses Virion Genome Genes and proteins Viruses and hosts Diseases Distinctive characteristics Virion Enveloped icosahedral capsid (T=16), diameter 125 nm Diameter of enveloped virion 200 nm Capsid

More information

T-cells and Aging. Jörg J Goronzy, M.D., Ph.D. Stanford University School of Medicine

T-cells and Aging. Jörg J Goronzy, M.D., Ph.D. Stanford University School of Medicine T-cells and Aging Jörg J Goronzy, M.D., Ph.D. Stanford University School of Medicine Cells Kinetics of T cell responses after vaccination 10 9 10 8 10 7 10 6 10 5 Ag Pre-existing T cell repertoire Differentiation

More information

Lung Disease in Pediatrics: is it all in the Genes?

Lung Disease in Pediatrics: is it all in the Genes? Lung Disease in Pediatrics: is it all in the Genes? Jay K. Kolls, M.D. Chair, Department of Genetics LSU Health Sciences Center New Orleans, LA Children s s Hospital of Pittsburgh Severe combined immunodeficiency

More information

Modulation de la différenciation lymphocytaire T par thérapie cellulaire et génique dans le thymus. Valérie Zimmermann

Modulation de la différenciation lymphocytaire T par thérapie cellulaire et génique dans le thymus. Valérie Zimmermann Modulation de la différenciation lymphocytaire T par thérapie cellulaire et génique dans le thymus Valérie Zimmermann Thymopoiesis Bone Marrow 2-28 days Thymus Periphery Hematopoietic progenitor Hematopoietic

More information

Darwinian selection and Newtonian physics wrapped up in systems biology

Darwinian selection and Newtonian physics wrapped up in systems biology Darwinian selection and Newtonian physics wrapped up in systems biology Concept published in 1957* by Macfarland Burnet (1960 Nobel Laureate for the theory of induced immune tolerance, leading to solid

More information

General information. Cell mediated immunity. 455 LSA, Tuesday 11 to noon. Anytime after class.

General information. Cell mediated immunity. 455 LSA, Tuesday 11 to noon. Anytime after class. General information Cell mediated immunity 455 LSA, Tuesday 11 to noon Anytime after class T-cell precursors Thymus Naive T-cells (CD8 or CD4) email: lcoscoy@berkeley.edu edu Use MCB150 as subject line

More information

Commercially available HLA Class II tetramers (Beckman Coulter) conjugated to

Commercially available HLA Class II tetramers (Beckman Coulter) conjugated to Class II tetramer staining Commercially available HLA Class II tetramers (Beckman Coulter) conjugated to PE were combined with dominant HIV epitopes (DRB1*0101-DRFYKTLRAEQASQEV, DRB1*0301- PEKEVLVWKFDSRLAFHH,

More information

Immune Regulation and Tolerance

Immune Regulation and Tolerance Immune Regulation and Tolerance Immunoregulation: A balance between activation and suppression of effector cells to achieve an efficient immune response without damaging the host. Activation (immunity)

More information

NK cell flow cytometric assay In vivo DC viability and migration assay

NK cell flow cytometric assay In vivo DC viability and migration assay NK cell flow cytometric assay 6 NK cells were purified, by negative selection with the NK Cell Isolation Kit (Miltenyi iotec), from spleen and lymph nodes of 6 RAG1KO mice, injected the day before with

More information

Standardization of Immune Biomarkers: Lessons From the HIV Field

Standardization of Immune Biomarkers: Lessons From the HIV Field Standardization of Immune Biomarkers: Lessons From the HIV Field Alan Landay, PhD Rush University Medical Center Thomas Denny, MSc Duke University Medical Center and Viral Load Standardization Immunology

More information

Olumiant (baricitinib) NEW PRODUCT SLIDESHOW

Olumiant (baricitinib) NEW PRODUCT SLIDESHOW Olumiant (baricitinib) NEW PRODUCT SLIDESHOW Introduction Brand name: Olumiant Generic name: Baricitinib Pharmacological class: Janus kinase (JAK) inhibitor Strength and Formulation: 2mg; tabs Manufacturer:

More information

Relevant Disclosures

Relevant Disclosures 6/18/215 Therapeutic developments for autoimmune demyelinating diseases: Musings from a MD (Mouse Doctor) Michael K. Racke, M.D. May 28, 215 Relevant Disclosures Editorial Boards for Journal of Neuroimmunology,

More information

Dr Anna Herasimtschuk

Dr Anna Herasimtschuk 19 th Annual Conference of the British HIV Association (BHIVA) Dr Anna Herasimtschuk Imperial College London 16-19 April 213, Manchester Central Convention Complex Therapeutic immunisation in conjunction

More information

Nature Medicine: doi: /nm.3922

Nature Medicine: doi: /nm.3922 Title: Glucocorticoid-induced tumor necrosis factor receptor-related protein co-stimulation facilitates tumor regression by inducing IL-9-producing helper T cells Authors: Il-Kyu Kim, Byung-Seok Kim, Choong-Hyun

More information

MATERIALS AND METHODS. Neutralizing antibodies specific to mouse Dll1, Dll4, J1 and J2 were prepared as described. 1,2 All

MATERIALS AND METHODS. Neutralizing antibodies specific to mouse Dll1, Dll4, J1 and J2 were prepared as described. 1,2 All MATERIALS AND METHODS Antibodies (Abs), flow cytometry analysis and cell lines Neutralizing antibodies specific to mouse Dll1, Dll4, J1 and J2 were prepared as described. 1,2 All other antibodies used

More information

Herpes Simplex Virus Type 1 and Alzheimer s disease:

Herpes Simplex Virus Type 1 and Alzheimer s disease: The Neurodegenerates Herpes Simplex Virus Type 1 and Alzheimer s disease: Increasing Evidence for a major role of the virus 1 Introduction and Agenda 2 Agenda What is the HSV1 and why is it linked to AD?

More information

The encephalitogenicity of TH17 cells is dependent on IL-1- and IL-23- induced production of the cytokine GM-CSF

The encephalitogenicity of TH17 cells is dependent on IL-1- and IL-23- induced production of the cytokine GM-CSF CORRECTION NOTICE Nat.Immunol. 12, 568 575 (2011) The encephalitogenicity of TH17 cells is dependent on IL-1- and IL-23- induced production of the cytokine GM-CSF Mohamed El-Behi, Bogoljub Ciric, Hong

More information

Cytokines modulate the functional activities of individual cells and tissues both under normal and pathologic conditions Interleukins,

Cytokines modulate the functional activities of individual cells and tissues both under normal and pathologic conditions Interleukins, Cytokines http://highered.mcgraw-hill.com/sites/0072507470/student_view0/chapter22/animation the_immune_response.html Cytokines modulate the functional activities of individual cells and tissues both under

More information

Immune monitoring in intensive care patients

Immune monitoring in intensive care patients 28th General annual Meeting of the Belgian Hematological Society Immune monitoring in intensive care patients Guillaume Monneret Head Cellular Immunology Unit Hôp. E. Herriot-Hospices Civilsde Lyon -F

More information

Innovation in Diagnostics. ToRCH. A complete line of kits for an accurate diagnosis INFECTIOUS ID DISEASES

Innovation in Diagnostics. ToRCH. A complete line of kits for an accurate diagnosis INFECTIOUS ID DISEASES Innovation in Diagnostics ToRCH A complete line of kits for an accurate diagnosis INFECTIOUS ID DISEASES EN TOXOPLASMOSIS Toxoplasmosis is a parasitic disease caused by with the obligate intracellular

More information

ImmunomodulaOon et sepsis : Actualités 2017

ImmunomodulaOon et sepsis : Actualités 2017 ImmunomodulaOon et sepsis : Actualités 2017 Guillaume Monneret Hôp. E. Herriot / Hospices Civils de Lyon EA 7426 - Pathophysiology of Injury- Induced Immunosuppression - U. Lyon 1 ISPB (School of Pharmacy)

More information

Supplementary Materials for

Supplementary Materials for www.sciencetranslationalmedicine.org/cgi/content/full/8/333/333ra47/dc1 Supplementary Materials for Androgen receptor antagonists compromise T cell response against prostate cancer leading to early tumor

More information

2/19/2018. The Immune System and Cancer. Fatal Melanoma Transferred in a Donated Kidney 16 years after Melanoma Surgery

2/19/2018. The Immune System and Cancer. Fatal Melanoma Transferred in a Donated Kidney 16 years after Melanoma Surgery F141: Advanced Melanoma: Mechanisms of Immune Therapies beyond Checkpoint blockade Delphine J. Lee, MD, PhD Chief and Program Director, Dermatology, Harbor UCLA Medical Center Principal Investigator, Los

More information

ACTIVATION AND EFFECTOR FUNCTIONS OF CELL-MEDIATED IMMUNITY AND NK CELLS. Choompone Sakonwasun, MD (Hons), FRCPT

ACTIVATION AND EFFECTOR FUNCTIONS OF CELL-MEDIATED IMMUNITY AND NK CELLS. Choompone Sakonwasun, MD (Hons), FRCPT ACTIVATION AND EFFECTOR FUNCTIONS OF CELL-MEDIATED IMMUNITY AND NK CELLS Choompone Sakonwasun, MD (Hons), FRCPT Types of Adaptive Immunity Types of T Cell-mediated Immune Reactions CTLs = cytotoxic T lymphocytes

More information

Persistent Infections

Persistent Infections Persistent Infections Lecture 17 Biology 3310/4310 Virology Spring 2017 Paralyze resistance with persistence WOODY HAYES Acute vs persistent infections Acute infection - rapid and self-limiting Persistent

More information

Disclosure Information. Mary L. Disis

Disclosure Information. Mary L. Disis Disclosure Information Mary L. Disis I have the following financial relationships to disclose: Consultant for: VentiRx, Celgene, Emergent, EMD Serono Speaker s Bureau for: N/A Grant/Research support from:

More information

Supplementary Figure 1. Deletion of Smad3 prevents B16F10 melanoma invasion and metastasis in a mouse s.c. tumor model.

Supplementary Figure 1. Deletion of Smad3 prevents B16F10 melanoma invasion and metastasis in a mouse s.c. tumor model. A B16F1 s.c. Lung LN Distant lymph nodes Colon B B16F1 s.c. Supplementary Figure 1. Deletion of Smad3 prevents B16F1 melanoma invasion and metastasis in a mouse s.c. tumor model. Highly invasive growth

More information

VIROLOGY. Mechanisms of Viral Pathogenesis

VIROLOGY. Mechanisms of Viral Pathogenesis VIROLOGY Mechanisms of Viral Pathogenesis The nature of host-virus interactions The virus genome must establish itself in a host population to endure Thus, viruses cannot be avoided; virus infections are

More information

Chapter 10 (pages ): Differentiation and Functions of CD4+ Effector T Cells Prepared by Kristen Dazy, MD, Scripps Clinic Medical Group

Chapter 10 (pages ): Differentiation and Functions of CD4+ Effector T Cells Prepared by Kristen Dazy, MD, Scripps Clinic Medical Group FIT Board Review Corner September 2015 Welcome to the FIT Board Review Corner, prepared by Andrew Nickels, MD, and Sarah Spriet, DO, senior and junior representatives of ACAAI's Fellows-In-Training (FITs)

More information

CD4CD8aa Lymphocytes, A Novel Human Regulatory T Cell Subset Induced by Colonic Bacteria and Deficient in Patients with Inflammatory Bowel Disease

CD4CD8aa Lymphocytes, A Novel Human Regulatory T Cell Subset Induced by Colonic Bacteria and Deficient in Patients with Inflammatory Bowel Disease CD4CD8aa Lymphocytes, A Novel Human Regulatory T Cell Subset Induced by Colonic Bacteria and Deficient in Patients with Inflammatory Bowel Disease Guillaume Sarrabayrouse 1,2,3,Céline Bossard 1,2,3, Joe-Marc

More information

HD1 (FLU) HD2 (EBV) HD2 (FLU)

HD1 (FLU) HD2 (EBV) HD2 (FLU) ramer staining + anti-pe beads ramer staining a HD1 (FLU) HD2 (EBV) HD2 (FLU).73.11.56.46.24 1.12 b CD127 + c CD127 + d CD127 - e CD127 - PD1 - PD1 + PD1 + PD1-1 1 1 1 %CD127 + PD1-8 6 4 2 + anti-pe %CD127

More information

Lab 3: Pathogenesis of Virus Infections & Pattern 450 MIC PRACTICAL PART SECTION (30397) MIC AMAL ALGHAMDI 1

Lab 3: Pathogenesis of Virus Infections & Pattern 450 MIC PRACTICAL PART SECTION (30397) MIC AMAL ALGHAMDI 1 Lab 3: Pathogenesis of Virus Infections & Pattern 450 MIC PRACTICAL PART SECTION (30397) 2018 450 MIC AMAL ALGHAMDI 1 Learning Outcomes The pathogenesis of viral infection The viral disease pattern Specific

More information

Supplementary Table 1: List of parameters used in this study. Parameter Unit Parameter Unit Clinical parameters CD4 T cells Microbial translocation

Supplementary Table 1: List of parameters used in this study. Parameter Unit Parameter Unit Clinical parameters CD4 T cells Microbial translocation Supplementary Table 1: List of parameters used in this study. Left table shows parameters available for all subjects and right table shows parameters available for a smaller subset of subjects. Parameters

More information

Regulatory B and T cell responses in patients with autoimmune thyroid disease and healthy controls

Regulatory B and T cell responses in patients with autoimmune thyroid disease and healthy controls Syddansk Universitet Regulatory B and T cell responses in patients with autoimmune thyroid disease and healthy controls Kristensen, Birte; Hegedüs, Laszlo Published in: Danish Medical Journal Publication

More information

Testing for Herpes Simplex Infections Getting it DONE!

Testing for Herpes Simplex Infections Getting it DONE! Testing for Herpes Simplex Infections Getting it DONE! Tens of millions of people have been diagnosed with herpes infections Genital Herpes Issues The Most Common Cause of Genital Ulceration is is Herpes

More information

The Promise of Adjuvant Epigenetic Therapy in Early Stage Esophageal Cancer. Zhihao Lu M.D. Peking University Cancer Hospital

The Promise of Adjuvant Epigenetic Therapy in Early Stage Esophageal Cancer. Zhihao Lu M.D. Peking University Cancer Hospital The Promise of Adjuvant Epigenetic Therapy in Early Stage Esophageal Cancer Zhihao Lu M.D. Peking University Cancer Hospital Current Treatment Strategies for Early Stage Esophageal Cancer Rate Prognosis

More information

Supplementary Figure 1. Enhanced detection of CTLA-4 on the surface of HIV-specific

Supplementary Figure 1. Enhanced detection of CTLA-4 on the surface of HIV-specific SUPPLEMENTARY FIGURE LEGEND Supplementary Figure 1. Enhanced detection of CTLA-4 on the surface of HIV-specific CD4 + T cells correlates with intracellular CTLA-4 levels. (a) Comparative CTLA-4 levels

More information

Replicating measles-shiv vaccine induces long term preservation of central memory CD4 cells in the gut of macaques challenged with SHIV89.

Replicating measles-shiv vaccine induces long term preservation of central memory CD4 cells in the gut of macaques challenged with SHIV89. Replicating measles-shiv vaccine induces long term preservation of central memory CD4 cells in the gut of macaques challenged with SHIV89.6P Frédéric Tangy Viral Genomics and Vaccination Laboratory Measles

More information

Rationale for Combining Immunotherapy with Chemotherapy or Targeted Therapy

Rationale for Combining Immunotherapy with Chemotherapy or Targeted Therapy Society for Immunotherapy of Cancer (SITC) Rationale for Combining Immunotherapy with Chemotherapy or Targeted Therapy Qing Yi, MD, PhD Staff and Chair, Department of Cancer Biology Betsy B. DeWindt Endowed

More information

HLA, tra immunità innata e adattativa

HLA, tra immunità innata e adattativa HLA, tra immunità innata e adattativa Emanuele Cozzi S.S.D. Immunologia dei Trapianti Azienda Ospedaliera di Padova Punti della presentazione Risultati attuali del trapianto e problematiche aperte Immunità

More information

IMMUNOLOGICAL MEMORY. CD4 T Follicular Helper Cells. Memory CD8 T Cell Differentiation

IMMUNOLOGICAL MEMORY. CD4 T Follicular Helper Cells. Memory CD8 T Cell Differentiation IMMUNOLOGICAL MEMORY CD4 T Follicular Helper Cells Memory CD8 T Cell Differentiation CD4 T Cell Differentiation Bcl-6 T-bet GATA-3 ROR t Foxp3 CD4 T follicular helper (Tfh) cells FUNCTION Provide essential

More information

IL-12 family members in experimental colitis. Markus F. Neurath I. Medical Clinic Johannes Gutenberg-University Mainz, Germany

IL-12 family members in experimental colitis. Markus F. Neurath I. Medical Clinic Johannes Gutenberg-University Mainz, Germany IL-12 family members in experimental colitis Markus F. Neurath I. Medical Clinic Johannes Gutenberg-University Mainz, Germany IBD - Pathogenesis Genetic Predisposition Bacterial Antigens Activation of

More information

Therapeutic effect of baicalin on experimental autoimmune encephalomyelitis. is mediated by SOCS3 regulatory pathway

Therapeutic effect of baicalin on experimental autoimmune encephalomyelitis. is mediated by SOCS3 regulatory pathway Therapeutic effect of baicalin on experimental autoimmune encephalomyelitis is mediated by SOCS3 regulatory pathway Yuan Zhang 1,2, Xing Li 1,2, Bogoljub Ciric 1, Cun-gen Ma 3, Bruno Gran 4, Abdolmohamad

More information

Therapeutic Immunization with Autologous DC Pulsed with Autologous Inactivated HIV-1 Infected Apoptotic Cells

Therapeutic Immunization with Autologous DC Pulsed with Autologous Inactivated HIV-1 Infected Apoptotic Cells Therapeutic Immunization with Autologous DC Pulsed with Autologous Inactivated HIV-1 Infected Apoptotic Cells Sharon A. Riddler, MD, MPH University of Pittsburgh May 2008 Slide 1 HIV and DC Vaccines During

More information

Effector T Cells and

Effector T Cells and 1 Effector T Cells and Cytokines Andrew Lichtman, MD PhD Brigham and Women's Hospital Harvard Medical School 2 Lecture outline Cytokines Subsets of CD4+ T cells: definitions, functions, development New

More information

Immune Tolerance. Kyeong Cheon Jung. Department of Pathology Seoul National University College of Medicine

Immune Tolerance. Kyeong Cheon Jung. Department of Pathology Seoul National University College of Medicine Immune Tolerance Kyeong Cheon Jung Department of Pathology Seoul National University College of Medicine Immune tolerance Unresponsiveness to an antigen that is induced by previous exposure to that antigen

More information

HIV AND LYMPHADENOPATHY

HIV AND LYMPHADENOPATHY HIV AND LYMPHADENOPATHY Sagren Naidoo Research report submitted to the Faculty of Health Sciences, University of the Witwatersrand, in partial fulfillment of the requirements for the degree of Master of

More information

Parallel session IVB. Chair: Hans Wildiers

Parallel session IVB. Chair: Hans Wildiers Parallel session IVB Biology of ageing and cancer Chair: Hans Wildiers IMMUNOSENESCENCE AND AGEING Tamas Fulop M.D., PhD Research Center on Aging, Division of Geriatrics, University of Sherbrooke, Sherbrooke,

More information

AGAINST VIRAL INFECTIONS. Identify the types of immunity involve in the mechanisms of protection against viral infections.

AGAINST VIRAL INFECTIONS. Identify the types of immunity involve in the mechanisms of protection against viral infections. LECTURE: 02 Title: THE IMMUNOLOGICAL PROTECTIVE MECHANISMS AGAINST VIRAL INFECTIONS LEARNING OBJECTIVES: The student should be able to: Identify the types of immunity involve in the mechanisms of protection

More information

Supplementalgfigureg1gSchematicgdiagramgofgtumor1modellingg

Supplementalgfigureg1gSchematicgdiagramgofgtumor1modellingg SChinjectionh F:LuchLCLsh IVhinjectionh T:cellsh Monitorhforhtumorh growthhandhxeno: reactivehgvhd GVLgexperimentg kcbgvsgpbgt1cellse Xeno1reactiveg experimentg kcbgvsgpbgt1cellse IVhinjectionh 5xh,N^6

More information

Cell-mediated Immunity

Cell-mediated Immunity Cellular & Molecular Immunology Cell-mediated Immunity Nicholas M. Ponzio, Ph.D. Department of Pathology & Laboratory Medicine April 6, 2009 Today s Presentation: Overview Cellular Interactions In Humoral

More information

Molecular mechanisms of the T cellinflamed tumor microenvironment: Implications for cancer immunotherapy

Molecular mechanisms of the T cellinflamed tumor microenvironment: Implications for cancer immunotherapy Molecular mechanisms of the T cellinflamed tumor microenvironment: Implications for cancer immunotherapy Thomas F. Gajewski, M.D., Ph.D. Professor, Departments of Pathology and Medicine Program Leader,

More information